Open AccessTriptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment
Author(s) -
Fang Wang,
Shujing An,
Yirong Yin,
Juanjuan Li,
Chunhui Sun,
Jie Lan,
Wenjuan Zhao,
Cheng-Qian Li
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
ISSN - 1177-8881
DOI - 10.2147/dddt.s322502
Subject(s) - triptolide , thyroid cancer , kegg , cancer research , in silico , tripterygium wilfordii , cancer , chemistry , apoptosis , pharmacology , biology , gene expression , medicine , biochemistry , pathology , gene , transcriptome , alternative medicine
Thyroid cancer is a familiar kind of cancer. Natural products are promising therapeutic approaches in treating thyroid cancer. Triptolide is a diterpenoid epoxide extracted from Tripterygium wilfordii . The mechanism of triptolide in the treatment of thyroid cancer has not been investigated clearly.